Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5036516014 | Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5036517017 | Levosulpiride 75 mg and rabeprazole sodium 20 mg gastro-resistant and prolonged-release oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Is a | Product containing only levosulpiride and rabeprazole in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Rabeprazole sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Rabeprazole sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Levosulpiride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has basis of strength substance | Levosulpiride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Gastro-resistant and prolonged-release oral tablet | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR